(Q43945108)

English

Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). (English)

1 reference

Europe PubMed Central

28 November 2017

0 references

object named as

Ana C Gales

3

0 references

Michael A. Pfaller

4

object named as

Michael A Pfaller

1 reference

Europe PubMed Central

28 November 2017

5

object named as

Ronald N Jones

1 reference

Europe PubMed Central

28 November 2017

author name string

Jan M Bell

1

1 reference

Europe PubMed Central

28 November 2017

John D Turnidge

2

1 reference

Europe PubMed Central

28 November 2017

Sentry APAC Study Group

6

1 reference

Europe PubMed Central

28 November 2017

publication date

1 March 2002

1 reference

Europe PubMed Central

28 November 2017

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

28 November 2017

42

1 reference

Europe PubMed Central

28 November 2017

3

1 reference

Europe PubMed Central

28 November 2017

193-198

1 reference

Europe PubMed Central

28 November 2017

A new plasmidic cefotaximase from patients infected withSalmonella typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A functional classification scheme for beta-lactamases and its correlation with molecular structure

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong KongNote

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

More extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmid-mediated production of class I (AmpC) beta-lactamase by two Klebsiella pneumoniae isolates from the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

beta-Lactamases of gram-negative bacteria: new challenges for new drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900353-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(01)00353-4

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43945108&oldid=2104564560"